Kodiak Sciences KOD
NASDAQ KOD
$35.36 -1.00 (-2.75%)
As of: Sep 4, 2026 · 3:59 PM EDT

Kodiak Sciences (KOD) Price to FCF (2018 - 2026)

Analysis

Kodiak Sciences (KOD) Price to FCF (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Kodiak Sciences 2.21 Bn 2.21 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -52.54
Mar 31, 2026 -57.86
Dec 31, 2025 -43.80
Sep 30, 2025 -26.38
Jun 30, 2025 -5.66
Mar 31, 2025 -5.05
Dec 31, 2024 -17.38
Sep 30, 2024 -6.44
Jun 30, 2024 -4.66
Mar 31, 2024 -6.97
Dec 31, 2023 -2.67
Sep 30, 2023 -2.86
Jun 30, 2023 -8.33
Mar 31, 2023 -5.46
Dec 31, 2022 -6.44
Sep 30, 2022 -6.60
Jun 30, 2022 -6.27
Mar 31, 2022 -6.61
Dec 31, 2021 -65.12
Sep 30, 2021 -87.40